Updated:
Psyched Wellness
Psyched Wellness Ltd., led by Justin Wilson, develops legal psychedelic-derived wellness products for North American markets. Publicly traded on the CSE.
Psyched Wellness
Psyched Wellness Ltd. was incorporated in Canada and is publicly traded on the Canadian Securities Exchange (CSE: PSYC). The firm's chief executive, Justin Wilson, oversees a team that includes chief financial officer Dave Casey and chief science officer Jeffrey Stevens. The company does not disclose a founding date or a single-family-office structure in its public filings, but its operations focus on the legal psychedelics space. The firm concentrates on developing and selling products containing plant-derived psychoactive compounds, such as Amanita muscaria (fly agaric mushroom) extracts, positioned as functional wellness supplements. Psyched Wellness has not reported a specific AUM or deployment tally, but it funds clinical research, product licensing, and manufacturing agreements. Its portfolio includes intellectual property around standardized extraction methods for controlled substances not classified as illicit in certain jurisdictions. The company targets North American consumers via e-commerce and retail distribution partnerships. Psyched Wellness employs a lean operational structure with no disclosed team size beyond named executives. The firm has not publicly stated the size of its investment capital or any family-office mandates. In October 2024, the company announced a licensing agreement for its Amanita muscaria extract products with a U.S. distributor, expanding its retail footprint (per CSE filings, October 2024). The firm's structural differentiator is its publicly traded status combined with a focus on legal but novel psychoactive ingredients — a space that straddles regulatory gray areas between supplements, novel foods, and controlled substances. This hybrid regulatory posture sets it apart from both conventional wellness companies and pure-play pharmaceutical psychedelics firms.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
Canada
City
Toronto
Corporate office
Toronto, Ontario, Canada
Principals
Justin Wilson
Chief Executive Officer
Dave Casey
Chief Financial Officer
Jeffrey Stevens
Chief Science Officer
Sector focus
Frequently asked questions
Who runs investment decisions at Psyched Wellness?
CEO Justin Wilson leads strategic and investment direction at Psyched Wellness. The firm does not publicly disclose an investment committee or a designated CIO; operational decisions are made by the executive team, including CFO Dave Casey and CSO Jeffrey Stevens, consistent with its public-company governance (per the firm's CSE filings, 2024).
How does Psyched Wellness source proprietary deal flow?
Psyched Wellness focuses on internal product development and licensing agreements rather than external deals. Its sourcing comes from relationships in the functional mushroom supply chain and academic researchers studying psychoactive compounds. The firm does not maintain a formal venture or private-equity sourcing operation (per the firm's public filings, 2024).
Is Psyched Wellness structured as a single family office or does it operate more like a venture firm?
Psyched Wellness is a publicly traded corporation on the Canadian Securities Exchange, not a registered family office or venture capital firm. Its board and officers manage deployed capital for R&D and commercialization. The firm does not disclose any single-family-office backing or wealth origin (per the firm's public filings, 2024).
Does Psyched Wellness participate in fund commitments or only direct deals?
Psyched Wellness does not make fund commitments; it operates as an operating company funding its own product development and licensing. There is no public evidence of it participating in external venture funds or SPVs (per the firm's public filings, 2024).
What investment stages does Psyched Wellness typically target?
Psyched Wellness does not target investment stages in the traditional sense. All capital is deployed internally into early-stage product R&D, clinical trials, and manufacturing scale-up. The firm's known spending is on development-stage assets for commercial distribution (per the firm's public filings, 2024).
Which sectors does Psyched Wellness explicitly avoid?
Psyched Wellness avoids any controlled substances regulated under the US Controlled Substances Act, such as psilocybin or LSD, focusing instead on legal psychoactive compounds like Amanita muscaria extracts. The firm also does not engage in cannabis or hemp-derived products (per the firm's public filings, 2024).
Does Psyched Wellness maintain philanthropic structures, and how are they separated?
Psyched Wellness does not publicly report any charitable foundations or philanthropic vehicles. All disclosed operational activity is commercial, focused on product development and distribution (per the firm's public filings, 2024).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: